Talk:Famotidine

From WikiProjectMed
Jump to navigation Jump to search

Famotidine was discovered by Yamanouchi Pharmaceutical Co., Ltd. who market fammotidine in Japan. Merck has license rights outside of Japan.

drug presentation

does any one give me an idea about drug presentation about pepcid? —Preceding unsigned comment added by 117.206.18.127 (talk) 15:26, 13 September 2009 (UTC)[reply]


No Pepcid anymore?

Guys I live in Austin TX and have noticed all Pepcid brand has been sold out. Big empty spaces where it used to be on all the store shelves. What's going on? Hanz ofbyotch (talk) 17:33, 1 November 2010 (UTC) Safeway in San Francisco is long sold out too. —Preceding unsigned comment added by 76.102.229.31 (talk) 20:25, 1 March 2011 (UTC)[reply]

Why does "Brolin redirects here"? "Brolin" isn't even mentioned anywhere on the page. 68.5.48.231 (talk) 21:00, 23 August 2015 (UTC)[reply]

See here: [1] Garzfoth (talk) 15:24, 24 August 2015 (UTC)[reply]

External links modified

Hello fellow Wikipedians,

I have just added archive links to one external link on Famotidine. Please take a moment to review my edit. If necessary, add {{cbignore}} after the link to keep me from modifying it. Alternatively, you can add {{nobots|deny=InternetArchiveBot}} to keep me off the page altogether. I made the following changes:

When you have finished reviewing my changes, please set the checked parameter below to true to let others know.

This message was posted before February 2018. After February 2018, "External links modified" talk page sections are no longer generated or monitored by InternetArchiveBot. No special action is required regarding these talk page notices, other than regular verification using the archive tool instructions below. Editors have permission to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the RfC before doing mass systematic removals. This message is updated dynamically through the template {{source check}} (last update: 18 January 2022).

  • If you have discovered URLs which were erroneously considered dead by the bot, you can report them with this tool.
  • If you found an error with any archives or the URLs themselves, you can fix them with this tool.

Cheers.—cyberbot IITalk to my owner:Online 03:03, 10 February 2016 (UTC)[reply]

Famotidine versus ranitidine, and other H2 antagonists - liver damage and other long-term side-effects

Can someone more versed on this subject provide more insight into the long-term side-effects of famotidine? The ranitidine article has well documented concerns about liver damage, possibly giving undue weight to the safety of drugs like famotidine, whose article doesn't raise any concerns about long-term side-effects. Since this drug falls under the same classification as ranitidine, I would think the side-effects are the same, unless the drugs are somehow metabolized differently. 98.86.105.139 (talk) 17:52, 6 June 2016 (UTC)[reply]

I don't see much on this topic in the ranitidine article, and comparing literature from both products suggests that ranitidine has a pretty weak link to liver damage and famotidine has no significant link. The only issue I see is that the B12 deficiency issue is not addressed in famotidine's article, but it's not crucial to fix that. If anything, I think the ranitidine article needs to be toned down a bit - it's overemphasizing rare side effects and misrepresenting trial data. Garzfoth (talk) 17:46, 19 June 2016 (UTC)[reply]

Cepal listed at Redirects for discussion

An editor has asked for a discussion to address the redirect Cepal. Please participate in the redirect discussion if you wish to do so. Abote2 (talk) 10:14, 20 May 2019 (UTC)[reply]

As a covid treatment?

For what is worth, Fox news is trumpeting this as yet another "treatment" for covid-19. Very little factual information is presented, which is why I'm only putting it into a note here. — Preceding unsigned comment added by 2001:8003:E414:3A01:B98C:A522:A492:8AEE (talk) 07:42, 19 August 2020 (UTC)[reply]

Studies:

Hcobb (talk) 17:21, 30 September 2020 (UTC)[reply]

And an AP article about the controversial trial process via Washington Post: https://www.washingtonpost.com/politics/trump-admin-21m-gambit-for-pepcid-as-a-covid-remedy-fizzles/2020/07/23/601337d6-cced-11ea-99b0-8426e26d203b_story.html —PaleoNeonate – 01:51, 6 August 2021 (UTC)[reply]
Sounds like information that should be included albeit properly contextualized w/ the lack of evidence. Chess (talk) (please use {{reply to|Chess}} on reply) 20:44, 4 September 2021 (UTC)[reply]

Famotidine led to earlier resolution of symptoms, without reducing anti-SARS-CoV-2 immunity. Patients self-administered 80 mg famotidine (n=28) or placebo (n=27) orally 3 times a day =240mg/day, for 14 consecutive days. Famotidine for treating reflux is taken at 10–40 mg a day, which is probably INsufficient to suppress anti-viral type-I interferon responses.

https://gut.bmj.com/content/early/2022/02/09/gutjnl-2022-326952

Additional randomised trials are required.

--91.159.188.74 (talk) 00:28, 19 February 2022 (UTC)[reply]

We'd need WP:MEDRS to include anything about this. Alexbrn (talk) 02:39, 19 February 2022 (UTC)[reply]

Famotidine has a delayed onset of action, BEGINNING after 90 minutes?

Wikipedia says: "Famotidine has a delayed onset of action, beginning after 90 minutes".

Why so slow? How can this be made quicker? By increasing dosage to 20mg, 30mg, 40mg, 50mg? Chewing the tablets? Other ideas?

Too bad, otherwise it would be a GREAT idea to take for example 20mg of Famotidine with 400mg or 800mg ibuprofen painkiller. Unless one knows in advance that one has a headache and takes Famotidine first.

As Ibuprofen increases stomach bleeding risk, Famotidine reduces this risk by about 50%?

91.159.189.212 (talk) 14:34, 3 June 2023 (UTC)[reply]

Famitidine & respiratory illnesses

Attached is a terrific paper explaining the rationale to begin exploring the utility of famotidine for respiratory illnesses that induce inflammatory pathways. Sure, famotidine may not kill a virus or bacteria, but it shows promise in treating the down stream inflammatory pathways associated respiratory illness.

Of note, understanding dosing to attain desired anti-inflammatory effects & possible drug-drug interactions is essential. Having a pharmacist involved in this decision process is important.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066957/ 2600:8804:B09:4900:293B:EE45:577F:598 (talk) 12:27, 20 April 2024 (UTC)[reply]

Retrieved from "https://mdwiki.org/wiki/Talk:Famotidine"